We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$1.69B
AUM Growth
+$78.1M
Cap. Flow
+$16.4M
Cap. Flow %
0.97%
Top 10 Hldgs %
18.04%
Holding
278
New
59
Increased
69
Reduced
68
Closed
61

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$15.2M
2
TENB icon
Tenable Holdings
TENB
+$14.5M
3
FN icon
Fabrinet
FN
+$11.4M
4
LIVN icon
LivaNova
LIVN
+$11.3M
5
ICUI icon
ICU Medical
ICUI
+$9.46M

Top Sells

Rank Stock Value
1
ACDC icon
ProFrac Holding
ACDC
+$20.5M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$15.9M
3
CUBI icon
Customers Bancorp
CUBI
+$13.9M
4
MTSI icon
MACOM Technology Solutions
MTSI
+$11.3M
5
PRFT
Perficient Inc
PRFT
+$10.8M

Sector Composition

Rank Sector Weight
1 Healthcare 30.48%
2 Technology 15.58%
3 Industrials 15.3%
4 Consumer Discretionary 13.22%
5 Financials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBNY
276
DELISTED
Signature Bank
SBNY
– –
-17,705
Closed -$2.04M
8 9 10 11
12

Similar funds

SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
YC
Yarbrough Capital Franklin, Tennessee $2.85B AUM 36.22% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's Q1 2023 Portfolio in Review

As of Q1 2023, Emerald Mutual Fund Advisers Trust held 278 positions worth $1.69B, up 4.8% from $1.61B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q1 2023 filing shows 59 new, 69 increased, 68 reduced and 61 closed positions. Its largest new stake was Fabrinet: 92,046 shares worth $10.9M. The largest sale was ProFrac Holding, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Emerald Mutual Fund Advisers Trust's largest Q1 2023 buy was Fabrinet: 92,046 shares worth $10.9M.
  • Emerald Mutual Fund Advisers Trust added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $15.2M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $15.9M.
  • Emerald Mutual Fund Advisers Trust fully exited ProFrac Holding in Q1 2023, selling an estimated $20.5M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 18% of its $1.69B portfolio in Q1 2023.
  • Emerald Mutual Fund Advisers Trust opened 59 new positions and closed 61 in Q1 2023.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 4.8% quarter-over-quarter to $1.69B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2023, filed 4 May 2023.